6-aminonicotinamide has been researched along with Heart Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupte, SA; Hintze, TH; Mania, D; Mitacchione, G; Patel, N; Qanud, K; Recchia, FA; Sarnari, R; Sosnowska, D; Stanley, WC; Ungvari, Z; Vimercati, C | 1 |
| Bellomo, M; Floyd, BC; Gupte, RS; Gupte, SA; Labinskyy, V; Levine, RJ; Lionetti, V; Ojaimi, C; Recchia, FA; Wolin, MS; Young, ME | 1 |
2 other study(ies) available for 6-aminonicotinamide and Heart Failure
| Article | Year |
|---|---|
Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart.
Topics: 6-Aminonicotinamide; Animals; Blood Glucose; Cardiotonic Agents; Dinoprost; Disease Models, Animal; Dogs; Gluconates; Glycolysis; Heart Failure; Male; Myocardium; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Pentose Phosphate Pathway; Recovery of Function; Stroke Volume; Superoxides; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2014 |
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart.
Topics: 6-Aminonicotinamide; Animals; Blood Pressure; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Enzyme Inhibitors; Glucosephosphate Dehydrogenase; Heart Failure; Humans; NADP; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Superoxides; Teratogens; Time Factors | 2006 |